Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.76 |
| ▸ | PTGS2 | P35354 | 18/20 | 0.73 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.73 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dimethylamine SCHEMBL9204674 | 0.95 | ALOX5 (0.69) | ALOX5PTGS2PTGS1AOC3CYP2C9 | |
| SCHEMBL12629112 | 0.89 | ALOX5 (0.80) | ALOX5PTGS2PTGS1CYP2C9 | |
| SCHEMBL2615132 | 0.88 | PTGS2 (0.76) | ALOX5PTGS2PTGS1CYP2C9 | |
| SCHEMBL8421061 | 0.86 | PTGS2 (0.88) | ALOX5PTGS2PTGS1AOC3CYP2C9 | |
| SCHEMBL9203342 | 0.86 | PTGS2 (0.73) | ALOX5PTGS2PTGS1AOC3CYP2C9 | |
| SCHEMBL17369546 | 0.86 | ALOX5 (1.00) | ALOX5PTGS2PTGS1CYP2C9 | |
| SCHEMBL16425767 | 0.86 | ALOX5 (0.70) | ALOX5PTGS2PTGS1AOC3CYP2C9 | |
| SCHEMBL28740979 | 0.85 | PTGS2 (0.71) | ALOX5PTGS2PTGS1AOC3CYP2C9 | |
| SCHEMBL9201743 | 0.85 | PTGS2 (0.71) | ALOX5PTGS2PTGS1AOC3CYP2C9 | |
| SCHEMBL9207256 | 0.85 | PTGS2 (0.71) | ALOX5PTGS2PTGS1AOC3CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080027011-A1 | Homogeneous paste and gel formulations | MERIAL LIMITED | 2008-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080027011-A1 | Homogeneous paste and gel formulations | EPX, CAT, PEF1 | ALOX5 1571/4885PTGS2 329/4885PTGS1 101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.